RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $1.678B (100.0% shares, 0.0% debt)

Holdings (32)

ASND ASCENDIS PHARMA A S 23.7%
Value $398M Shares 4,132,442 Share Price $96.32 Est. Cost/Share $17.96 Unrealized @ Report Date —
WVE WAVE LIFE SCIENCES LTD 9.5%
Value $160M Shares 7,775,207 Share Price $20.53 * Est. Cost/Share $17.26 Unrealized @ Report Date +32.9%
— SYNTHORX INC 9.4%
Value $158M Shares 9,724,598 Share Price $16.27 Est. Cost/Share $17.38 Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 6.8%
Value $115M Shares 4,858,260 Share Price $23.65 Est. Cost/Share $8.41 Unrealized @ Report Date —
— ZOGENIX INC 5.4%
Value $90.52M Shares 2,260,751 Share Price $40.04 Est. Cost/Share $37.11 Unrealized @ Report Date —
— EIDOS THERAPEUTICS INC 4.6%
Value $77.79M Shares 2,162,671 Share Price $35.97 Est. Cost/Share $20.34 Unrealized @ Report Date —
RYTM RHYTHM PHARMACEUTICALS INC 4.4%
Value $73.89M Shares 3,422,312 Share Price $21.59 Est. Cost/Share $25.19 Unrealized @ Report Date -14.8%
— SATSUMA PHARMACEUTICALS INC 4.2%
Value $70.28M Shares 4,681,858 Share Price $15.01 Est. Cost/Share $15.01 Unrealized @ Report Date —
— ORCHARD THERAPEUTICS PLC 3.7%
Value $62.07M Shares 5,224,475 Share Price $11.88 Est. Cost/Share $15.75 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 2.8%
Value $47.27M Shares 4,571,164 Share Price $10.34 Est. Cost/Share $8.67 Unrealized @ Report Date —
— RETROPHIN INC 2.8%
Value $46.22M Shares 3,987,560 Share Price $11.59 Est. Cost/Share $11.59 Unrealized @ Report Date —
— PREVAIL THERAPEUTICS INC 2.5%
Value $41.3M Shares 3,363,605 Share Price $12.28 Est. Cost/Share $13.03 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 2.3%
Value $38.63M Shares 6,880,323 Share Price $5.61 * Est. Cost/Share $12.35 Unrealized @ Report Date -43.5%
ARVN ARVINAS INC 2.1%
Value $35.85M Shares 1,663,512 Share Price $21.55 * Est. Cost/Share $16.46 Unrealized @ Report Date +49.1%
— DICERNA PHARMACEUTICALS INC 2.1%
Value $35.28M Shares 2,456,669 Share Price $14.36 Est. Cost/Share $18.43 Unrealized @ Report Date —
— MYOVANT SCIENCES LTD 1.9%
Value $32.07M Shares 6,166,875 Share Price $5.20 Est. Cost/Share $12.18 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS INC 1.7%
Value $28.2M Shares 1,875,209 Share Price $15.04 * Est. Cost/Share $29.55 Unrealized @ Report Date -34.2%
STOK STOKE THERAPEUTICS INC 1.4%
Value $24.07M Shares 1,119,963 Share Price $21.49 * Est. Cost/Share $26.85 Unrealized @ Report Date +3.8%
— SCPHARMACEUTICALS INC 1.1%
Value $19.06M Shares 3,247,005 Share Price $5.87 Est. Cost/Share $11.02 Unrealized @ Report Date —
— KALA PHARMACEUTICALS INC 1.0%
Value $17.27M Shares 4,537,478 Share Price $3.80 Est. Cost/Share $13.25 Unrealized @ Report Date —
— PRECISION BIOSCIENCES INC 0.9%
Value $15.46M Shares 1,842,366 Share Price $8.39 Est. Cost/Share $17.95 Unrealized @ Report Date —
KOD KODIAK SCIENCES INC 0.9%
Value $14.74M Shares 1,025,165 Share Price $14.38 * Est. Cost/Share $13.06 Unrealized @ Report Date 0.0%
ALEC ALECTOR INC 0.9%
Value $14.42M Shares 1,000,000 Share Price $14.42 * Est. Cost/Share $18.92 Unrealized @ Report Date -4.6%
AXSM AXSOME THERAPEUTICS INC 0.8%
Value $13.45M Shares 664,385 Share Price $20.24 * Est. Cost/Share $9.29 Unrealized @ Report Date +176.7%
— PORTOLA PHARMACEUTICALS INC 0.7%
Value $11.52M Shares 429,399 Share Price $26.82 Est. Cost/Share $26.82 Unrealized @ Report Date —
— DYNAVAX TECHNOLOGIES CORP 0.5%
Value $8.458M Shares 2,365,912 Share Price $3.57 Est. Cost/Share $3.57 Unrealized @ Report Date —
— IGM BIOSCIENCES INC 0.5%
Value $8.278M Shares 466,368 Share Price $17.75 Est. Cost/Share $17.75 Unrealized @ Report Date —
— X4 PHARMACEUTICALS INC 0.4%
Value $6.077M Shares 478,107 Share Price $12.71 Est. Cost/Share $15.00 Unrealized @ Report Date —
— ODONATE THERAPEUTICS INC 0.3%
Value $5.206M Shares 200,000 Share Price $26.03 Est. Cost/Share $36.69 Unrealized @ Report Date —
— CHIMERIX INC 0.2%
Value $4.188M Shares 1,782,202 Share Price $2.35 Est. Cost/Share $2.35 Unrealized @ Report Date —
— ESSA PHARMA INC 0.2%
Value $3.37M Shares 1,000,000 Share Price $3.37 Est. Cost/Share $3.37 Unrealized @ Report Date —
— SENSEONICS HLDGS INC 0.2%
Value $2.696M Shares 2,727,273 Share Price $0.99 Est. Cost/Share $0.99 Unrealized @ Report Date —